Quantcast

Latest Oncology Stories

2014-10-29 00:21:55

LONDON, Oct. 28, 2014 /PRNewswire/ -- Malignant Melanoma: PD-1 inhibitors revolutionise treatment is a comprehensive report with insights from 12 leading US and European KOLs offering their latest views on current and late-stage pipeline products, why and when they would prescribe them, and the factors likely to affect their future positioning and competitiveness.The recent US approval of Merck's PD-1 inhibitor Keytruda (pembrolizumab) and the expected approval of BMS' Opdivo...

2014-10-28 23:03:44

The family medical practice is now an accredited Lung Cancer Screening Center. Evans, GA (PRWEB) October 28, 2014 Center for Primary Care has been designated a Lung Cancer Screening Center by the American College of Radiology (ACR). The ACR Lung Cancer Screening Center designation is a voluntary program which recognizes facilities that have committed to practice safe, effective diagnostic care for individuals at the highest risk for lung cancer. In order to receive this elite...

2014-10-28 12:31:13

The Program is Jointly Funded by LLS and Janssen Research & Development, LLC WHITE PLAINS, N.Y., Oct. 28, 2014 /PRNewswire-USNewswire/ -- The Leukemia & Lymphoma Society has initiated a program to fund research projects seeking to better understand and, ultimately, stop progression of certain types of blood cancers from early-stage malignancies to much more lethal states of disease. The types of early-stage blood cancers the program will focus on are the "myeloid" diseases, such...

2014-10-27 23:11:13

In CHAMPS Oncology's most recent blog post, Representing Your Patients in the NCDB, Ilona Gyerman shares her thoughts on the topic. Cleveland, Ohio (PRWEB) October 27, 2014 In CHAMPS Oncology's most recent blog post, Representing Your Patients in the NCDB, Ilona Gyerman shares her thoughts on the topic. Each year cancer registrars submit thousands of cases to the National Cancer Data Base (NCDB) during the NCDB’s Annual Call for Data, explains Gyerman. This data provides...

2014-10-27 23:08:29

In recognition of October as Breast Cancer and Domestic Violence Awareness Month, the Elgin Elite Advocates at Computer Systems Institute is working to raise awareness of breast cancer. The awareness efforts of the EEA include the sale of pink items that include mints, stickers, bookmarks and bracelets to show their support for this important cause. Elgin, Illinois (PRWEB) October 27, 2014 Computer Systems Institute’s Elgin Elite Advocates (EEA) is selling items including bracelets,...

2014-10-27 23:03:16

Cosmetic and medical treatment spa is donating 5% of proceeds from cosmetic services to local breast cancer research and treatment efforts as part of Breast Cancer Awareness Month Reno, NV (PRWEB) October 27, 2014 Reno Sparks MedSpa, located in Reno, Nevada, is participating in a fundraiser for breast cancer research during Breast Cancer Awareness Month in October. Reno Sparks MedSpa's staff has partnered with the Susan G. Komen Foundation by pledging 5% of the month's proceeds...

2014-10-27 23:00:55

A report released by the Spanish Ministry of Health finds that mesothelioma is “grossly under-recognized” in Spain. Raleigh, NC (PRWEB) October 28, 2014 Researchers in Spain say many workers who contract mesothelioma after on-the-job asbestos exposure are not getting the recognition and compensation to which they are entitled. Surviving Mesothelioma has just posted an article on the new research. Click here to read it now. Healthcare researchers at Spain’s Ministry of Health and...

2014-10-27 08:29:11

QUEENSLAND, Australia, Oct. 27, 2014 /PRNewswire/ -- Cancer patients on the Gold Coast of Queensland have gained access to treatments on an advanced TrueBeam(TM) radiotherapy and radiosurgery system from Varian Medical Systems (NYSE: VAR). Queensland's first TrueBeam device commenced treatments at Genesis CancerCare Queensland's treatment center located at John Flynn Hospital in Tugun last week. The Varian TrueBeam(TM) system, which integrates advanced treatment, imaging and motion...

2014-10-27 04:21:55

- Tosedostat Currently in Phase 2 Development for Patients with AML and MDS - SEATTLE, Oct. 27, 2014 /PRNewswire/ -- CTI BioPharma Corp. (CTI) (NASDAQ and MTA: CTIC) today announced that it has acquired worldwide rights to tosedostat through concurrent transactions with Vernalis R&D Limited (Vernalis), the originator of tosedostat, and Chroma Therapeutics Ltd. (Chroma), through which CTI previously held a sublicense with respect to tosedostat in North, Central and South America....

2014-10-25 23:01:49

Japanese doctors say they may have found a way around the toxicity problem of standard drug treatment for mesothelioma. Raleigh, NC (PRWEB) October 25, 2014 Mesothelioma researchers are reporting extended survival in a mesothelioma patient who continued to receive pemetrexed (Alimta), after his combination drug therapy became too toxic. Click here to read the full story, just posted on the Surviving Mesothelioma website. A new case study from Uji Tokushukai Medical Center in Japan...


Word of the Day
ambsace
  • Bad luck; misfortune.
  • The smallest amount possible or the most worthless thing.
The word 'ambsace' comes from a Latin word meaning 'both'.